EP1890676A2 - Blends of inactive particles and active particles - Google Patents

Blends of inactive particles and active particles

Info

Publication number
EP1890676A2
EP1890676A2 EP06742446A EP06742446A EP1890676A2 EP 1890676 A2 EP1890676 A2 EP 1890676A2 EP 06742446 A EP06742446 A EP 06742446A EP 06742446 A EP06742446 A EP 06742446A EP 1890676 A2 EP1890676 A2 EP 1890676A2
Authority
EP
European Patent Office
Prior art keywords
particles
blend
coating
composition
inactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06742446A
Other languages
German (de)
English (en)
French (fr)
Inventor
Christian Sommer
Erik Kjær MARKUSSEN
Ole Simonsen
Poul Bach
Robert Van Der Lans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes AS filed Critical Novozymes AS
Publication of EP1890676A2 publication Critical patent/EP1890676A2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0039—Coated compositions or coated components in the compositions, (micro)capsules
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D8/00—Methods for preparing or baking dough
    • A21D8/02—Methods for preparing dough; Treating dough prior to baking
    • A21D8/04—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
    • A21D8/042—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/02—Inorganic compounds ; Elemental compounds
    • C11D3/04—Water-soluble compounds
    • C11D3/046—Salts
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38609—Protease or amylase in solid compositions only

Definitions

  • the present invention relates to a blend comprising active comprising particles and inactive particles as means to control the activity strength of particulate materials.
  • the present invention further relates to avoiding segregation in said blend.
  • WO 2003/094899 relates to production of compositions for programmed release of enalapril.
  • Inactive nuclei are prepared from sugar and starch.
  • a binder solution is added to the nuclei where after a micronized enalapril maleate active drug is added thereto and subsequently covered with talc.
  • One part of the granules are further coated e.g. with ethyl cellulose.
  • the coated and uncoated granules are mixed to form a desired release profile.
  • inactive core particles with an inactive material and use the coating as a means of controlling size, density or appearance of the granulate and to use these inactive coated granules to control activity of a granulate comprising active containing granules is new.
  • One object of the present invention is to provide means for adjusting and controlling the activity strength of a composition of active comprising particles. Another object of the present invention is to provide means for avoiding segregation of the above mentioned mixture. A third object is to prepare inactive particles with same visual appearance as particles comprising an active compound.
  • the present invention provides thus in a first aspect a blend of particles comprising at least two different kinds of particles: i) particles comprising an active compound and; ii) inactive particles comprising a coating.
  • the invention further provides methods for preparing said blend.
  • the terms "particle” or “granule” are intended to be understood as predominantly spherical or near spherical structures of a macromolecular size.
  • activity when used in reference to an enzyme preparation or with reference to an enzyme particle or an enzyme core is a relative measure of the ability of the enzyme in the preparation, granule or core to react with a standard substrate at fixed standard conditions. Activity is measured in units which are defined as ⁇ moles of substrate reacted per minute per gram of the measured sample at fixed standard conditions (herein after "a standard assay"). The activity is also a measure of the amount of active enzyme protein.
  • An enzyme has a specific activity which is the activity of the pure enzyme protein in the standard assay. The specific activity is also measured in units which are defined as ⁇ moles of substrate reacted per minute per gram of pure enzyme at fixed standard conditions.
  • the amount of pure enzyme protein in a sample can be calculated. If a 1 gram sample of a pure enzyme reacts with 100 ⁇ moles of a substrate per minute in a standard assay, the specific activity of the enzyme is 100 Units per gram pure enzyme. If a 1 gram sample of unknown enzyme activity reacts with 50 ⁇ moles of a substrate per minute in the standard assay, the activity of the sample is 50 Units per gram and there is 0.5 g of pure enzyme protein in the sample.
  • the term "activity”, when used in reference to an enzyme or with reference to a granule, is to be understood as intending to mean the efficacy with which the enzyme or granule performs its intended task. With regard to an enzyme, this relates to its biocatalytic, such as metabolic, process. With regard to a granule, this relates to its overall intended task as designed in the overall formulation.
  • the term “strength” relates to the activity of an enzyme or enzyme comprising particle in terms of its efficacy.
  • particle size of the granule is meant the diameter obtained by measurements with sieves.
  • particle size it can either mean the diameter of one particle or the mean size of a batch of particles depending on the context.
  • particle size ratio is given by the particle size of the inactive particles divided by the particle size of the particles comprising an active compound and is hereinafter abbreviated
  • particle size distribution is meant to be understood as the range of sizes of granules resulting from a particular process; the spectrum or gradient distribution of particles with regards to their diameter.
  • PSD particle size distribution
  • a mean mass diameter of D50 is the diameter at which 50% of the granules, by mass, have a smaller diameter, while 50% by mass have a larger diameter.
  • the values D10 and D90 are the diameters at which 10% and 90%, respectively, of the granules, by mass, have a smaller diameter than the value in question.
  • the “span” indicates the breadth of the PSD and is expressed as: (D90 - D10) / D50.
  • particle density ratio is the particle density of the inactive particles divided by the density of the particles comprising active compounds and is hereinafter abbreviated:
  • the segregation coefficient is given in absolute values.
  • the segregation of the present invention is measured in a rolling bed according to the following method:
  • 600 ml mixed particles are treated in a rolling bed.
  • the rolling bed exists of a plastic cylinder, length 299 mm, width 89 mm.
  • the cylinder is open at the top and placed in an inclination angle of 15°.
  • the cylinder is washed with Rodalon and dried.
  • the cylinder is rotated by a motor with 45-55 rpm for 5 minutes. After rotation for 5 minutes the top half of the granules are removed from the cylinder.
  • the average concentration of one kind of particle in both the top and bottom section is determined.
  • the difference in concentration of the different particles between the top and the bottom section is a measure of the segregation potential of a particulate mixture.
  • the method described here is similar to the one described by Williams J. C. and Khan M.I. (The Chemical Engineer, 19-25, January 1973). Another known method for measuring segregation is the heap tester.
  • the heap tester is a rectangular vessel with transparent walls. Its dimensions are: length 450 mm, diameter 38 mm and height 300 mm. Due to the narrow diameter it is also called a 2- dimensional heap.
  • a funnel is placed in the center above the vessel. The funnel is filled with granular material and emptied into the vessel. The flow of material forms a so-called 2- dimensional heap with its top at the center of the vessel.
  • the heap is divided into sections or compartments with slicers. The slicers are pushed down into the heap and physically separate the slope into equally spaced sections along the flow direction of the granules. Samples are taken from the top of each section with a suction system. The concentration of one component in each section is determined. The difference in concentration between the center and sides of the heap is a measure of the segregation potential of a granular mixture.
  • compositions comprising a specific active compound can normally be obtained in a variety of activity strengths depending on the application the composition has to be applied to.
  • To produce particles with a variety of different activity strengths for one specific active compound re- quires that a new batch is produced for each different activity strength needed, which is costly and time consuming. Furthermore large storage facilities are needed for all of the different activity strength particles to be on stock.
  • simple non-coated inactive cores in a batch of active compound containing particles to adjust the activity strength of a batch has, however, shown several negative aspects.
  • One problem occurring when adding simple inactive cores e.g. salt particles to active compound containing particles is segregation of the simple inactive cores and the active compound containing particles, due to difference in density and size, another problem is that the simple inactive cores are visual in the batch.
  • the solution to these negative aspects and to the use of simple inactive cores is to prepare inactive particles either matching the appearance of active compound containing particles or otherwise altering particle density and/or size distribution and/or surface properties (sphericity, roughness etc) in order to prevent segregation.
  • the main parameters which are used in the present invention to prevent segregation are adjustment of particle size and particle density.
  • One way of avoiding segregation is to prepare inactive particles with more or less equivalent density and particle size as the particles comprising active compounds.
  • the density of the inactive particles results in segregation as it either is too high or too low, segregation can be prevented by adjusting the particle size of the particles. If the density of the inactive particles is higher than the particle density of the active containing particles resulting in segregation the particle size of the inactive particles has to be increased to level out segrega- tion. If the density of the inactive particles is lower than the density of the active containing particles resulting in segregation, the size of the active comprising particles has to be increased to avoid segregation. The density of the materials used to change the particle sizes is also important.
  • the blend of the invention is preferably a premix or intermediary product to be used in an industrial process to prepare a final product.
  • the blend of the invention is on powder form.
  • One object of the present invention is to prevent segregation.
  • Segregation of particles is mainly a problem of particles with a particle size above 50 ⁇ m.
  • the particles of the invention have in a particular embodiment a particle size of at least 50 ⁇ m. In a more particular embodiment the particle size is at least 100 ⁇ m. In a most particular embodiment the particle size is at least 200 ⁇ m. In a particular embodiment of the present invention the particle sizes are between 100 ⁇ m to 2500 ⁇ m. In a more particular embodiment of the present invention the particle size is between 200 ⁇ m to 1200 ⁇ m. In an even more particular embodiment the particle size is between 250 ⁇ m to 850 ⁇ m. In a most particular embodiment the particle size is between 450 ⁇ m to 650 ⁇ m.
  • the main parameters affecting segregation are particle size and particle density. If the particle densities are not equal, segregation may be minimized by shifting the size distribution towards larger or smaller size. A larger particle size will compensate for higher density and vice versa.
  • the particle size distribution is normally as narrow as possible.
  • the span of the particles according to the invention is therefore typically not more than about 2.5, preferably not more than about 2.0, more preferably not more than about 1.5, and most preferably not more than about 1.0 or even not more than 0.5. In a particular embodiment the span of the particles are between 0.1 to 0.9.
  • One way of obtaining a narrow particle size distribution of the blend of particles is to coat the inactive particles so as to obtain a particle size distribution of the inactive particles approximating the particle size distribution of the active particles.
  • One way of avoiding segregation may be to adjust the density of the inactive particles to match the active compound containing particles.
  • Another way of avoiding segregation may be to increase or decrease the density of the inactive particles depending on the particle size of the active compound containing particles and the inactive particles. If a size difference between the active and inactive particles is unwanted, the particle densities must be about equal to avoid segregation.
  • the difference in density of the inactive particles and the active particles is less than 1.5 g/ml, such as less than 1 g/ml, even less than 0.5 g/ml.
  • the difference in density of the inactive particles and the active particles is less than 0.25 g/ml.
  • the difference in density of the inactive particles and the active particles is less than 0.1 g/ml.
  • /D pA is in a particular embodiment of the present invention between 0.5 and 2 such as between 0.6 and 1.4. In a more particular embodiment of the present invention the particle size ratio is between 0.7 and 1.3. In an even more particular embodiment of the present invention the particle size ratio is between 0.8 and 1.2. In an even further embodiment the particle size ratio is between 0.9 and 1.1. In a most particular embodiment of the present invention the particle size is between 0.95 and 1.05.
  • the segregation coefficient is less than 0.3. In a more particular embodiment of the present invention the segregation coefficient is less than 0.2. In an even more particular embodiment the segregation coefficient is less than 0.15. In an even further embodiment the segregation coefficient is less than 0.1. In a most particular embodiment the segregation coefficient is less than 0.08 even less than 0.06 such as less than 0.05.
  • the segregation coefficient is determined by a rolling bed test.
  • the average particle density is between 0.3 to 3.0 g/ml. In a more particular embodiment of the present invention the average particle den- sity is between 0.8 to 2.5 g/ml. In an even more particular embodiment of the present invention the average particle density is between 1.5 g/ml to 2.1 g/ml.
  • the particle density ratio of the inactive particles and the active comprising particles is in a particular embodiment of the present invention between 0.5 and 2. In a more particular embodiment of the present invention the particle density ratio is between 0.6 and 1.4. In an even more particular embodiment of the present invention the particle density ratio is between 0.7 and 1.3. In an even further embodiment the particle density ratio is between 0.8 and 1.2. In an even further particular embodiment of the present invention the particle density ratio is between 0.9 and 1.1. In a most particular embodiment of the present invention the particle density ratio is between 1.05 and 0.95.
  • the particle density is measured by the pycnometer method which is well known in the art. A 150 ml volumetric flask is used and 20-70 g samples are tested.
  • the flask is filled to the line with nonionic surfactant (linear secondary alcohol ethoxylate, 12-14 alkyl carbons, 4.5-5.5 mole EO, viscosity at 25°C of 25-40 cPs, surface tension 26-30 dyne/cm, HLB 9-12, specific gravity at 2O 0 C of 0.93-0.99 g/ml, e.g. Softanol 50 from lneos Oxide) and the particle density is calculated from the measured volume of the flask, the weight of the flask filled with only non- ionic surfactant (density of the surfactant), the weight of the sample and the weight of the flask with sample and nonionic surfactant.
  • nonionic surfactant linear secondary alcohol ethoxylate, 12-14 alkyl carbons, 4.5-5.5 mole EO, viscosity at 25°C of 25-40 cPs, surface tension 26-30 dyne/cm, HLB 9-12, specific gravity
  • a batch of particles has a homogeneous appearance which often is a requirement from customers. It may be of importance that the particles resemble the particles they are mixed with in composition e.g. detergent particles. However in some cases it may be better to be able to visually distinguish between active and inactive particles, this would provide a quick insight in how well mixed there are.
  • the Hunter Lab color analysis method may be used where delta values ⁇ L, ⁇ a, ⁇ b and ⁇ E are used. These values indicate how much a standard and a sample differs in color from one another.
  • the colour difference ⁇ E between the inactive particles and the particles comprising active compounds is less than 6. In a more particular embodiment of the present invention the colour difference ⁇ E between the inactive particles and the particles comprising active compounds is less than 5. In an even more particular embodiment of the present invention the colour difference ⁇ E between the inactive particles and the particles comprising active compounds is less than 4. In a most particular embodiment of the present invention the colour difference ⁇ E between the inactive particles and the particles comprising active compounds is less than 3.
  • the particles of the invention may comprise but are not limited to one or more of the following components: binders, polysaccharides, synthetic polymers, waxes, fillers, fibre materials, enzyme stabilizing agents, solubilising agents, crosslinking agents, suspension agents, viscosity regulating agents, light spheres, plasticizers, pigments, salts and lubricants.
  • the particles of the invention are preferably spherical or near spherical.
  • Polysaccharides The polysaccharides of the present invention may be un-modified naturally occurring polysaccharides or modified polysaccharides.
  • Suitable polysaccharides include cellulose, pectin, dextrin and starch.
  • the starches may be soluble or insoluble in water.
  • the polysaccharide is a starch.
  • the polysaccharide is an insoluble starch.
  • Naturally occurring starches from a wide variety of plant sources are suitable in the context of the invention (either as starches per se, or as the starting point for modified starches), and relevant starches include starch from: rice, corn, wheat, potato, oat, cassava, sago-palm, yuca, barley, sweet potato, sorghum, yams, rye, millet, buckwheat, arrowroot, taro, tannia, and may for example be in the form of flour.
  • Cassava starch is among preferred starches in the context of the invention; in this connection it may be mentioned that cassava and cassava starch are known under various synonyms, including tapioca, manioc, mandioca and manihot.
  • modified starch denotes a natu- rally occurring starch, which has undergone some kind of at least partial chemical modification, enzymatic modification, and/or physical or physicochemical modification, and which - in general - exhibits altered properties relative to the "parent" starch.
  • the granule comprise a polysaccharide.
  • synthetic polymers polymers which backbone has been polymerised synthetically.
  • Suitable synthetic polymers of the invention includes in particular polyvinyl pyrrolidone (PVP), polyvinyl alcohol (PVA), polyvinyl acetate, polyacrylate, polymethacrylate, poly-acrylamide, polysulfonate, polycarboxylate, and copolymers thereof, in particular water soluble polymers or copolymers.
  • the synthetic polymer is a vinyl polymer.
  • a “wax” in the context of the present invention is to be understood as a polymeric material having a melting point between 25 -15O 0 C, particularly 30 to100°C more particularly 35 to 85°C most particularly 40 to 75°C.
  • the wax is preferably in a solid state at room temperature, 25 0 C.
  • the lower limit is preferred to set a reasonable distance between the temperature at which the wax starts to melt to the temperature at which the granules or compositions comprising the granules are usually stored, 20 to 30°C.
  • a “wax composition” in this context is to be understood as mixture comprising two or more waxes. Such compositions usually have a melting range rather than a melting point.
  • the temperature at which the wax composition start to melt is called T m ⁇ i
  • T m,m The temperature at which all wax solids are melted
  • T m,e The median melting point in this context is defined as the temperature at which 50% w/w of the solids in the wax are melted.
  • the T m ⁇ i of the wax composition is more than 25°C.
  • the T mii of the wax composition is more than 3O 0 C.
  • the T m ,i of the wax composition is more than 35 0 C.
  • the melting range is calculated as the difference in degrees celcius between the temperature at which all wax solids are melted (T m , e ) and the temperature at which the wax composition starts to melt (T m, j).
  • a preferable feature of the wax is that the wax should be water soluble or water dispersible, particularly in neutral and alkaline solution, so that when the coated particles of the invention is introduced into an aqueous solution, i.e. by diluting it with water, the wax should disintegrate and/or dissolve providing a quick release and dissolution of the active incorporated in the particles to the aqueous solution.
  • water soluble waxes are poly ethylene glycols (PEG's).
  • PEG's poly ethylene glycols
  • t water insoluble waxes which are dispersible in an aqueous solution are triglycerides and oils.
  • the coating contains some insoluble waxes e.g. feed granules.
  • the wax composition is a hydrophilic composition.
  • at least 25 % w/w of the constituents comprised in the wax composition is soluble in water, preferably at least 50% w/w, preferably at least 75% w/w, preferably at least 85% w/w, preferably at least 95% w/w, preferably at least 99% w/w.
  • the wax composition is hydrophilic and dispersible in an aqueous solution.
  • the wax composition comprise less than 75% w/w hydrophobic constituents, preferably less than 50% w/w, preferably less than 25% w/w, preferably less than 15% w/w, preferably less than 5% w/w, preferably less than 1 % w/w.
  • the wax composition comprise less than 75% w/w water insoluble constituents, preferably less than 50% w/w, preferably less than 25% w/w, preferably less than 15% w/w, preferably less than 5% w/w, preferably less than 1 % w/w.
  • Suitable waxes are organic compounds or salts of organic compounds having one or more of the above mentioned properties.
  • the wax composition may preferably constitute at least 10 % by weight of the coating material, more preferably at least 20 % by weight of the coating material.
  • the wax composition of the invention may comprise any wax, which is chemically synthesized. It may also equally well comprise waxes isolated from a natural source or a derivative thereof. Accordingly, the wax composition of the invention may comprise waxes selected from the following non limiting list of waxes.
  • Poly ethylene glycols PEG.
  • Different PEG waxes are commercially available having different molecular sizes, wherein PEG's with low molecular sizes also have low melting points.
  • suitable PEG's are PEG 1500, PEG 2000, PEG 3000, PEG 4000, PEG 6000, PEG 8000, PEG 9000 etc. e.g. from BASF (Pluriol E series) or from Clariant or from Ineos. Derivatives of Poly ethylene glycols may also be used.
  • Polypropylenes e.g. polypropylene glycol Pluriol P series from BASF
  • polyethylenes or mixtures thereof e.g. polypropylene glycol Pluriol P series from BASF
  • Derivatives of polypropylenes and polyethylenes may also be used.
  • Nonionic surfactants which are solid at room temperature such as ethoxylated fatty alcohols having a high level of ethoxy groups such as the Lutensol AT series from BASF, a C16-C18 fatty alcohol having different amounts of ethyleneoxide per molecule, e.g. Lutensol AT11 , AT13, AT25, AT50, AT80, where the number indicate the average number of ethyleneoxide groups.
  • ethoxylated fatty alcohols having a high level of ethoxy groups such as the Lutensol AT series from BASF, a C16-C18 fatty alcohol having different amounts of ethyleneoxide per molecule, e.g. Lutensol AT11 , AT13, AT25, AT50, AT80, where the number indicate the average number of ethyleneoxide groups.
  • polymers of ethyleneoxide, propyleneox- ide or copolymers thereof are useful, such as in block polymers, e.g. Pluronic PE 6800 from BASF. Derivative
  • Waxes isolated from a natural source such as Camauba wax (melting point between 80-88 0 C), Candelilla wax (melting point between 68-70 0 C) and bees wax.
  • Mono-glycerides and/or di-glycerides such as glyceryl stearate, wherein stearate is a mixture of stearic and palmitic acid, are useful waxes.
  • glyceryl stearate wherein stearate is a mixture of stearic and palmitic acid
  • stearate is a mixture of stearic and palmitic acid
  • Fatty acids such as hydrogenated linear long chained fatty acids and derivatives of fatty acids.
  • Paraffines i.e. solid hydrocarbons.
  • waxes which are useful in the invention can be found in CM. McTaggart et. al., Int. J. Pharm. 19, 139 (1984) or Flanders et. al., Drug Dev. Ind. Pharm. 13, 1001 (1987) both incorporated herein by reference.
  • the wax of the present invention is a mixture of two or more different waxes.
  • the wax or waxes is selected from the group consisting of PEG, ethoxylated fatty alcohols, fatty acids, fatty acid alcohols and glyc- erides.
  • the waxes are chosen from synthetic waxes.
  • the waxes of the present invention are PEG or non- ionic surfactants.
  • the wax is PEG.
  • Suitable fillers are water soluble and/or insoluble inorganic salts such as finely ground alkali sulphate, alkali carbonate and/or alkali chloride, clays such as kaolin (e.g. SPESWHITETM, English China Clay), bentonites, talcs, zeolites, chalk, calcium carbonate and/or silicates.
  • kaolin e.g. SPESWHITETM, English China Clay
  • Pure or impure cellulose in fibrous form such as sawdust, pure fibrous cellulose, cotton, or other forms of pure or impure fibrous cellulose.
  • filter aids based on fibrous cellulose can be used.
  • Several brands of cellulose in fibrous form are on the market, e.g. CEPOTM and ARBOCELLTM.
  • Pertinent examples of fibrous cellulose filter aids are ARBOCELL BFC 200TM and ARBOCELL BC 200TM.
  • synthetic fibres may be used as described in EP 304331 B1 and typical fibres may be made of polyethylene, polypropylene, polyester, especially nylon, polyvinylformate, poly(meth)acrylic compounds.
  • Enzyme stabilizing agents Enzyme stabilising or protective agents such as conventionally used in the field of granulation may be elements of the core or the coating. Stabilising or protective agents may fall into several categories: alkaline or neutral materials, reducing agents, antioxidants and/or salts of first transition series metal ions. Each of these may be used in conjunction with other protective agents of the same or different categories. Examples of alkaline protective agents are alkali metal silicates, carbonates or bicarbonates, which provide a chemical scavenging effect by actively neutralising e.g. oxidants.
  • reducing protective agents are salts of sulfite, thi- osulfite, thiosulfate or MnSO 4 while examples of antioxidants are methionine, butylated hy- droxytoluene (BHT) or butylated hydroxyanisol (BHA).
  • stabilising agents may be salts of thiosulfates, e.g. sodium thiosulfate or methionine.
  • enzyme stabilizers may be bo- rates, borax, formates, di- and tricarboxylic acids and reversible enzyme inhibitors such as organic compounds with sulfhydryl groups or alkylated or arylated boric acids.
  • boron based stabilizer examples include boron based stabilizer and a preferred boron based stabilizer is 4-Formyl-Phenyl-Boronic Acid or derivatives thereof described in WO 96/41859 both disclosures incorporated herein by reference.
  • useful enzyme stabilizers are gelatine, casein, Poly vinyl pyrrolidone (PVP) and powder of skimmed milk.
  • the amounts of protective agent in the coating may be 5-40% w/w of the coating, particularly 5-30%, e.g. 10-
  • Solubilising agents The solubility of the coating is especially critical in cases where the coated particle is a component of a detergent formulation. As is known by the person skilled in the art, many agents, through a variety of methods, serve to increase the solubility of formulations, and typical agents known to the art can be found in National Pharmacopeia's.
  • Light spheres are small particles with low true density. Typically, they are hollow spherical particles with air or gas inside. Such materials are usually prepared by expanding a solid material. These light spheres may be inorganic of nature such as SCOTCHLITETM Glass Bubbles from 3MTM (hollow glass spheres), Q-CEL® (hollow microspheres of borosilicate glass) and/or Ex- tendospheres® (ceramic hollow spheres) available from The PQ Corporation. The light spheres may also be of organic nature such as the PM-series (plastic hollow spheres) available from The PQ Corporation.
  • Expancel® (hollow plastic spheres) from AKZO Nobel, Luxsil® and Sphericel® from Potters Industries and/or Styrocell® from SHELL, which is spheres of polystyrene.
  • the polystyrene of Styrocell® contains pentane which upon heating boils and ex- pands or pops the material (the reaction is comparable to the expansion of corn seeds into popcorn) leaving a light polystyrene material of a low true density.
  • polysaccharides are preferred, such as starch or derivatives thereof.
  • Biodac® is an example of non-hollow lightweight material made from cellulose (waste from papermaking), available from GranTek Inc. These materials may be included in the granules of the invention either alone or as a mixture of different light materials.
  • Cross linking agents such as enzyme-compatible surfactants, e.g. ethoxylated alcohols, especially ones with 10 to 80 ethoxy groups. These may both be found in the coating and in the core particle.
  • Suspension agents mediators (for boosting bleach action upon dissolution of the particle in e.g. a washing application) and/or solvents may be incorporated in the particles.
  • Viscosity regulating agents :
  • Viscosity regulating agents may be present in the particles.
  • Plasticizers useful in coating layers in the context of the present invention include, for example: polyols such as sugars, sugar alcohols, glycerine, glycerol trimethylol propane, neopentyl glycol, triethanolamine, mono-, di- and Methylene glycol or polyethylene glycols (PEGs) having a molecular weight less than 1000; urea, phthalate esters such as dibutyl or dimethyl phthalate; thiocyanates, non-ionic surfactants such as ethoxylated alcohols and ethoxylated phosphates and water.
  • polyols such as sugars, sugar alcohols, glycerine, glycerol trimethylol propane, neopentyl glycol, triethanolamine, mono-, di- and Methylene glycol or polyethylene glycols (PEGs) having a molecular weight less than 1000
  • urea phthalate esters such as dibutyl or dimethyl phthalate
  • Suitable pigments include, but are not limited to, finely divided whiteners, such as titanium dioxide or kaolin, coloured pigments, water soluble colorants, as well as combinations of one or more pigments and water soluble colorants.
  • a whitening agent e.g. TiO 2 can be incorporated in the granules.
  • the salt may be an inorganic salt, e.g. salts of sulfate, sulfite, phosphate, phosphonate, nitrate, chloride or carbonate or salts of simple organic acids (less than 10 carbon atoms e.g. 6 or less carbon atoms) such as citrate, malonate or acetate.
  • simple organic acids less than 10 carbon atoms e.g. 6 or less carbon atoms
  • Examples of cations in these salt are alkali or earth alkali metal ions, although the ammonium ion or metal ions of the first transition series, such as sodium, potassium, magnesium, calcium, zinc or aluminium.
  • anions include chloride, bromide, iodide, sulfate, sulfite, bisulfite, thiosulfate, phosphate, monobasic phosphate, dibasic phosphate, hypophosphite, dihydrogen pyrophosphate, tetraborate, borate, carbonate, bicarbonate, metasilicate, citrate, malate, maleate, malonate, succinate, lactate, formate, acetate, butyrate, propionate, benzoate, tartrate, ascorbate or gluconate.
  • alkali- or earth alkali metal salts of sulfate, sulfite, phosphate, phosphonate, nitrate, chloride or carbonate or salts of simple organic acids such as citrate, malonate or acetate may be used.
  • Specific examples include NaH 2 PO 4 , Na 2 HPO 4 , Na 3 PO 4 , (NH 4 )H 2 PO 4 , K 2 HPO 4 , KH 2 PO 4 , Na 2 SO 4 , K 2 SO 4 , KHSO 4 , ZnSO 4 , MgSO 4 , CuSO 4 , Mg(NO 3 ) 2 , (NH 4 ) 2 SO 4 , sodium borate, magnesium acetate and sodium citrate.
  • the salt may also be a hydrated salt, i.e. a crystalline salt hydrate with bound water(s) of crystallization, such as described in WO 99/32595.
  • hydrated salts include magnesium sulfate heptahydrate (MgSO 4 (7H 2 O)), zinc sulfate heptahydrate (ZnSO 4 (7H 2 O)), copper sulfate pentahydrate (CuSO 4 (5H 2 O)), sodium phosphate dibasic heptahydrate (Na 2 HPO 4 (ZH 2 O)), magnesium nitrate hexahydrate (Mg(NO 3 ) 2 (6H 2 O)), sodium borate decahydrate, sodium citrate dihydrate and magnesium acetate tetrahydrate.
  • lubricant refers to any agent, which reduces surface friction, lubricates the surface of the granule, decreases tendency to build-up of static electricity, and/or reduces friability of the granules.
  • Lubricants can also play a related role in improving the coating process, by reducing the tackiness of binders in the coating.
  • lubricants can serve as anti-agglomeration agents and wetting agents.
  • suitable lubricants are lower polyethylene glycols (PEGs), ethoxylated fatty alcohols and mineral oils.
  • the lubricant is particularly a mineral oil or a nonionic surfactant, and more particularly the lubricant is not mis- proficient with the other coating materials.
  • the construction of the inactive particles may be a homogeneous mixture throughout the particle or it may be a layered particle.
  • the inac- tive particle comprise an inactive core particle upon which at least one coating is applied.
  • Inactive core particles such as placebo particles, carrier particles, inactive nuclei, inert particles, non-pareil particles, non active particles or seeds are particles not comprising active compounds upon which a coating mixture comprising the active compound can be layered. They may be formulated with organic or inorganic materials such as inorganic salts, sugars, sugar alcohols, small organic molecules such as organic acids or salts, starch, cellulose, polysaccharides, minerals such as clays or silicates or a combination of two or more of these. In a particular embodiment of the present invention the particles to be coated are inactive particles.
  • the material of the core particles are selected from the group consisting of inorganic salts, sugar alcohols, small organic molecules, starch, cellulose and minerals.
  • the particles are not made of alkali metal silicates.
  • the core particles have in a particular embodiment of the present invention a particle size of at least 50 ⁇ m. In a more particular embodiment the core particle size is at least 100 ⁇ m. In a most particular embodiment the core particle size is at least 150 ⁇ m. In a particular embodiment of the present invention the core particle sizes are between 50 ⁇ m to 1200 ⁇ m. In a more particular embodiment of the present invention the core particle size is between 100 ⁇ m to 800 ⁇ m. In an even more particular embodiment the core particle size is between 125 ⁇ m to 450 ⁇ m. In a most particular embodiment the core particle size is between 150 ⁇ m to 350 ⁇ m or even 200 ⁇ m to 300 ⁇ m.
  • the coating or coatings applied to the inactive core particles are used to obtain the desired feature of the inactive particle being e.g. a specific density or a specific size or size distribution.
  • the coating may further be used to obtain the same or similar appearance as the particles comprising active compounds.
  • the coating applied to the inactive core particles may be but are not limited to any coating known from pharmaceutical and enzymatic products.
  • the coating may comprise one or more conventional shell or coating components such as described in WO 89/08694, WO 89/08695, 270 608 B1 and/or WO 00/01793.
  • Other examples of conventional coating materials may be found in US 4,106,991 , EP 170360, EP 304332, EP
  • the coating is not an organo diphosphonate.
  • inactive core particles it is difficult to obtain the desired features of the particle simply by encapsulating the inactive core particles with a thin coating, hence it is desirable to apply several coatings or a thick coating such as coatings known from WO 01/25412 hereby incorporated by reference.
  • the inactive granule of the invention has a structure wherein D P /D C is at least 1.1, which means that the thickness of the shell unit is at least 5% of the core unit diameter.
  • D P /D C for the granule is at least 1.05, more particularly at least 1.25, more particularly at least 1.5, even more particularly at least 2, most particularly at least 3.
  • D P /D C is however particularly below about 100, particularly below about 50, more particularly below 25, and most particularly below 10.
  • the coating is at least 10 ⁇ m thick. In a more particular embodiment the thickness is at least 25 ⁇ m such as at least 50 ⁇ m, at least 75 ⁇ m, at least 100 ⁇ m, at least 150 ⁇ m, at least 200 ⁇ m or most particularly at least 300 ⁇ m.
  • the coating constitutes at least 5% of the total granule by weight In a more particular embodiment of the present invention the coating constitutes at least 10% by weight of the total granule. In an even more particular embodiment the coating constitutes at least 25% by weight, even such as 50% by weight. In an even further embodiment the coating constitutes at least 75% by weight of the total granule. In a most particular embodiment of the present invention the coating constitutes at least 90% by weight of the total granule even such as 95% by weight of the total granule.
  • the coating constitutes at least 5% of the total granule by volume In a more particular embodiment of the present invention the coating constitutes at least 10% by volume of the total granule. In an even more particular embodiment the coating constitutes at least 25% by volume, even such as 50% by volume. In an even further embodiment the coating constitutes at least 75% by volume of the total granule. In a most particular embodiment of the present invention the coating constitutes at least 90% by volume of the total granule even such as 95% by volume of the total granule.
  • the density of inert core particles is usually higher than the density of particles comprising active compounds. Therefore it is often a benefit that the coatings used to alter the size and the density of the inactive particles has a lower density than the density of the inert core particles to be able to obtain the desired effect.
  • the difference between the density of the coating and the core of the particles is at least 5%. In a more particular embodiment of the present invention the difference between the density of the coating and the core of the particles is at least 10%. In an even more particular embodiment the difference between the density of the coating and the core of the particles is at least 25%. In a most particular embodiment the difference between the density of the coating and the core of the particles is at least 50%.
  • the density of the coating is at least 5% lower than the density of the core. In a more particular embodiment of the present invention the density of the coating is at least 10% lower than the density of the core. In an even more particular embodiment of the present invention the density of the coating is at least 25% lower than the density of the core. In a most particular embodiment of the present invention the density of the coating is at least 50% lower than the density of the core.
  • the particle density of the coated particle p P is given from the particle density of the core pc and the coating p coa ti n g and the diameters:
  • the particle density and particle size of the coated particle are measured, as well as the core density and size.
  • the coating density can be calculated using the formula above.
  • Granules comprising an active compound
  • the granules comprising active compounds may be any granule formulated to comprise an active compound.
  • One object of the present invention is to provide a way of obtaining any desired activity strength of a granulate comprising active compounds in an easy way.
  • the idea is to produce a high strength granule (a granule with a high activity) and mix it together with a granule that has either no activity or low activity compared to the high activity granule, such as to provide a method for diluting the high strength granules to any desired activity strength.
  • the activity strength of the high activity granule is at least 4 times higher than the activity of the low activity granule.
  • the activity strength of the high activity granule is at least 10 times higher than the activity of the low activity granule.
  • the activity strength of the high activity granule is at least 100 times higher than the activity of the low activity granule. If a low activity granule is used to dilute the high activity granules instead of inactive granules, everything related to the inactive granule disclosed in this description does also apply to the low activity granule.
  • the active compound of the present invention either present in the core or in the coating may be any active compound or mixture of active compounds, which benefits from being separated from the environment surrounding the granule.
  • active is meant to encompass all compounds, which upon release from the coated particle upon applying the coated particle of the invention in a process, serve a purpose of improving the process.
  • the active compound may be inorganic of nature or organic of nature.
  • Particularly active compounds are active biological compounds which are usually very sensitive to the surrounding environment such as compounds obtainable from microorganisms. More particularly active compounds are peptides or polypeptides or proteins. Most particularly active compounds are proteins such as enzymes.
  • active compounds are bleaches, growth promoters, antibiotics, antigenic determinants to be used as vaccines, polypeptides engineered to have an increased content of essential amino acids, hormones and other therapeutic proteins.
  • the active compounds are proteins.
  • the proteins are enzymes.
  • the enzyme in the context of the present invention may be any enzyme or combination of different enzymes. Accordingly, when reference is made to an "enzyme” this will in general be understood to include one enzyme or a combination of enzymes.
  • enzyme variants are included within the meaning of the term "enzyme”. Examples of such enzyme variants are disclosed, e.g. in EP 251 ,446 (Genencor), WO 91/00345 (Novo Nordisk), EP 525,610 (Solvay) and WO 94/02618 (Gist-Brocades NV). Enzymes can be classified on the basis of the handbook Enzyme Nomenclature from NC- IUBMB, 1992), see also the ENZYME site at the internet: http://www.expasy.ch/enzvme/. ENZYME is a repository of information relative to the nomenclature of enzymes.
  • IUB-MB International Union of Biochemistry and Molecular Biology
  • glycoside hydrolase enzymes such as endoglucanase, xy- lanase, galactanase, mannanase, dextranase and alpha-galactosidase
  • endoglucanase xy- lanase
  • galactanase galactanase
  • mannanase mannanase
  • dextranase alpha-galactosidase
  • alpha-galactosidase alpha-galactosidase
  • the types of enzymes which may be incorporated in particles of the invention include oxidoreductases (EC 1.-.-.-), transferases (EC 2.-.-.-), hydrolases (EC 3.-.-.-), lyases (EC 4.-.-).
  • Preferred oxidoreductases in the context of the invention are peroxidases (EC 1.11.1 ), laccases (EC 1.10.3.2) and glucose oxidases (EC 1.1.3.4)].
  • An Example of a commercially available oxidoreductase (EC 1.-.-.-) is GluzymeTM (enzyme available from Novozymes A/S).
  • transferases are transferases in any of the following sub-classes: a Transferases transferring one-carbon groups (EC 2.1); b transferases transferring aldehyde or ketone residues (EC 2.2); acyltransferases (EC 2.1).
  • a most preferred type of transferase in the context of the invention is a transglutaminase
  • transglutaminases are described in WO 96/06931 (Novo Nordisk
  • Preferred hydrolases in the context of the invention are: carboxylic ester hydrolases (EC 3.1.1.-) such as lipases (EC 3.1.1.3); phytases (EC 3.1.3.-), e.g. 3-phytases (EC 3.1.3.8) and
  • 6-phytases EC 3.1.3.26
  • glycosidases EC 3.2, which fall within a group denoted herein as
  • Carbohydrases such as ⁇ -amylases (EC 3.2.1.1); peptidases (EC 3.4, also known as proteases); and other carbonyl hydrolases.
  • ⁇ -amylases EC 3.2.1.1
  • peptidases EC 3.4, also known as proteases
  • other carbonyl hydrolases examples include Bio-FeedTM Phytase (Novozymes), RonozymeTM P (DSM Nutritional Products), NatuphosTM (BASF), FinaseTM (AB Enzymes), and the PhyzymeTM product series (Danisco).
  • carbohydrase is used to denote not only enzymes capable of breaking down carbohydrate chains (e.g. starches or cellulose) of especially five- and six- membered ring structures (i.e. glycosidases, EC 3.2), but also enzymes capable of isomerizing carbohydrates, e.g. six-membered ring structures such as D-glucose to five-membered ring structures such as D-fructose.
  • Carbohydrases of relevance include the following (EC numbers in parentheses): ⁇ -amylases (EC 3.2.1.1), ⁇ -amylases (EC 3.2.1.2), glucan 1 ,4- ⁇ -glucosidases (EC 3.2.1.3), endo-1 ,4-beta-glucanase (cellulases, EC 3.2.1.4), endo-1 ,3(4)- ⁇ -glucanases (EC 3.2.1.6), endo-1 ,4- ⁇ -xylanases (EC 3.2.1.8), dextranases (EC 3.2.1.11), chitinases (EC 3.2.1.14), poly- galacturonases (EC 3.2.1.15), lysozymes (EC 3.2.1.17), ⁇ -glucosidases (EC 3.2.1.21), ⁇ - galactosidases (EC 3.2.1.22), ⁇ -galactosidases (EC 3.2.1.23), amylo-1
  • proteases examples include KannaseTM, EverlaseTM, EsperaseTM, AlcalaseTM, NeutraseTM, DurazymTM, SavinaseTM, OvozymeTM, PyraseTM, Pancreatic Trypsin NOVO (PTN), Bio-FeedTM Pro and Clear-LensTM Pro (all available from Novozymes A/S, Bagsvaerd, Denmark).
  • Other preferred proteases include those described in WO 01/58275 and WO 01/58276.
  • proteases include RonozymeTM Pro, MaxataseTM, MaxacalTM, MaxapemTM, OpticleanTM, PropeaseTM, PurafectTM and Purafect OxTM (available from Genencor International Inc., Gist-Brocades, BASF, or DSM Nutritional Products).
  • lipases include LipexTM, LipoprimeTM, LipopanTM, LipolaseTM, LipolaseTM Ultra, LipozymeTM, PalataseTM, ResinaseTM, NovozymTM 435 and LecitaseTM (all available from Novozymes A/S).
  • lipases include LumafastTM (Pseudomonas mendocina lipase from Genencor International Inc.); LipomaxTM (Ps. pseudoalcaligenes lipase from Gist- Brocades/Genencor Int. Inc.; and Bacillus sp. lipase from Solvay enzymes. Further lipases are available from other suppliers.
  • carbohydrases examples include Alpha-GalTM, Bio-FeedTM Alpha, Bio-FeedTM Beta, Bio-FeedTM Plus, Bio-FeedTM Wheat, Bio-FeedTM Z, NovozymeTM 188, CarezymeTM, CelluclastTM, CellusoftTM, CelluzymeTM, CeremylTM, CitrozymTM, DenimaxTM, DezymeTM, DextrozymeTM, DuramylTM, EnergexTM, FinizymTM, FungamylTM, GamanaseTM, GlucanexTM, LactozymTM, LiquezymeTM, MaltogenaseTM, NatalaseTM, PentopanTM, PectinexTM, PromozymeTM, PulpzymeTM, NovamylTM, TermamylTM, AMGTM (Amyloglucosidase Novo), MaltogenaseTM, SweetzymeTM and AquazymTM (all available from Novozymes A/S).
  • carbohydrases are available from other suppliers, such as the RoxazymeTM and RonozymeTM product series (DSM Nutritional Products), the AvizymeTM, PorzymeTM and GrindazymeTM product series (Danisco, Finnfeeds), and NatugrainTM (BASF) , PurastarTM and PurastarTM OxAm (Genencor).
  • Other commercially available enzymes include MannawayTM, PectawayTM, StainzymeTM and RenozymeTM.
  • Suitable lipases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful lipases include lipases from Humicola (synonym Thermomyces), e.g. from H. lanuginosa (T. lanuginosus) as described in EP 258 068 and EP 305 216 or from H. insolens as described in WO 96/13580, a Pseudomonas lipase, e.g. from P. alcaligenes or P. pseudoalcaligenes (EP 218 272), P. cepacia (EP 331 376), P. stutzeri (GB 1,372,034), P.
  • lipase variants such as those described in WO 92/05249, WO 94/01541, EP 407 225, EP 260 105, WO 95/35381 , WO 96/00292, WO 95/30744, WO 94/25578, WO 95/14783, WO 95/22615, WO 97/04079 and WO 97/07202.
  • lipases include LIPEX, LIPOPRIMETM, LIPOLASETM, LIPOLASETM Ultra, LIPOZYMETM, PALATASETM, NOVOZYMTM 435 and LECITASETM (all available from Novozymes A/S).
  • lipases include LUMAFASTTM (Pseudomonas mendocina lipase from Genencor International Inc.); LIPOMAXTM [Ps. pseudoalcaligenes lipase from DSM/Genencor Int. Inc.; and Bacillus sp. lipase from Genencor enzymes. Further lipases are available from other suppliers.
  • carbohydrases examples include ALPHA-GALTM, BIO-FEEDTM Alpha, BIO-FEEDTM Beta, BIO-FEEDTM Plus, BIO-FEEDTM Plus, NOVOZYMETM 188, CELLU- CLASTTM, CELLUSOFTTM, CEREMYLTM, CITROZYMTM, DENIMAXTM, DEZYMETM, DEX- TROZYMETM, FINIZYMTM, FUNGAMYLTM, GAMANASETM, GLUCANEXTM, LACTOZYMTM, MALTOGENASETM, PENTOPANTM, PECTINEXTM, PROMOZYMETM, PULPZYMETM, NOVA- MYLTM, TERMAMYLTM, AMGTM (Amyloglucosidase Novo), MALTOGENASETM, SWEETZYMETM and AQUAZYMTM (all available from Novozymes A/S).
  • Amylases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, ⁇ -amylases obtained from Bacillus, e.g. a special strain of B. licheniformis, described in more detail in GB 1 ,296,839.
  • Examples of useful amylases are the variants described in WO 94/02597, WO 94/18314, WO 96/23873, and WO 97/43424, especially the variants with substitutions in one or more of the fol- lowing positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 181 , 188, 190, 197, 202, 208, 209, 243, 264, 304, 305, 391 , 408, and 444.
  • amylases are NATALASETM, STAINZYMETM, DURAMYLTM, TERMA- MY 1 TM 1 TERMAMYLTM ULTRA, FUNGAMYLTM and BANTM (Novozymes A/S), RAPI- DASETM, PURASTARTM and PURASTAR OXAMTM (from Genencor International Inc.).
  • Suitable cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g. the fungal cellulases produced from Humicola insolens, Myceliophthora thermophila and Fusarium oxysporum dis- closed in US 4,435,307, US 5,648,263, US 5,691,178, US 5,776,757 and WO 89/09259.
  • cellulases are the alkaline or neutral cellulases having colour care benefits.
  • Examples of such cellulases are cellulases described in EP 0 495 257, EP 0 531 372, WO 96/11262, WO 96/29397, WO 98/08940.
  • Other examples are cellulase variants such as those described in WO 94/07998, EP 0 531 315, US 5,457,046, US 5,686,593, US 5,763,254, WO 95/24471 , WO 98/12307 and PCT/DK98/00299.
  • Oxidoreductases Particular oxidoreductases in the context of the invention are peroxidases (EC 1.11.1), laccases (EC 1.10.3.2) and glucose oxidases (EC 1.1.3.4)].
  • An Example of a commercially available oxidoreductase (EC 1.-.-.-) is GLUZYMETM (enzyme available from Novozymes A/S).
  • Peroxidases/Oxidases Suitable peroxidases/oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful per- oxidases include peroxidases from Coprinus, e.g. from C. cinereus, and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257. Commercially available peroxidases include GUARDZYMETM (Novozymes A/S). Mannanase: Any mannanase suitable for use in alkaline solutions can be used. Suitable mannanases include those of bacterial or fungal origin. Chemically or genetically modified mutants are included.
  • the mannanase is derived from a strain of the genus Bacillus, especially Bacillus sp. I633 disclosed in positions 31-330 of SEQ ID NO:2 or in SEQ ID NO: 5 of WO 99/64619 or Bacillus agaradhaerens, for example from the type strain DSM 8721.
  • the mannanase is derived from Alkalo- philic bacillus.
  • Suitable mannanases include MANNAWAYTM (Novozymes A/S).
  • Pectate lyase Any pectate lyase suitable for use in alkaline solutions can be used. Suitable pectate lyases include those of bacterial or fungal origin. Chemically or genetically modified mutants are included.
  • the pectate lyase is derived from a strain of the genus Bacillus, es- pecially a strain of Bacillus substilis, especially Bacillus subtilis DSM14218 disclosed in SEQ ID NO:2 or a variant thereof disclosed in Example 6 of WO 02/092741.
  • the pectate lyase is derived from Bacillus licheniformis.
  • the active compound is not a pharmaceutical.
  • the particles of the invention may be formulated by any conventional formulation methods known in the art. Methods for preparing the particles include known enzyme formulation technologies e.g. spray drying, fluid bed, fluid bed spray drying, mixer granulation and extrusion. Other relevant particles are layered products, absorbed products, pelletized products, prilled products. The particles may optionally be dried after granulation.
  • Methods for preparing the particles include known enzyme formulation technologies e.g. spray drying, fluid bed, fluid bed spray drying, mixer granulation and extrusion.
  • Other relevant particles are layered products, absorbed products, pelletized products, prilled products.
  • the particles may optionally be dried after granulation.
  • Preparation methods include known enzyme granule formulation technologies, i.e.:
  • granulates consisting of enzyme as active compound, fillers and binders etc. are mixed with cellulose fibres to reinforce the particles to give the so-called T- granulate. Reinforced particles, being more robust, release less enzymatic dust.
  • Fluid bed granulation involves suspending particulates in an air stream and spraying an enzyme liquid onto the fluidized particles via nozzles. Particles hit by spray droplets get wetted and become tacky. The tacky particles collide with other particles and adhere to them and form a granule.
  • the cores may be subjected to drying, such as in a fluid bed drier.
  • drying preferably takes place at a product temperature of from 25 to 9O 0 C.
  • the cores comprising the enzymes contain a low amount of water before coating with the salt. If water sensitive active compounds are coated with a salt before excessive water is removed, it will be trapped within the core and it may affect the activity of the enzyme negatively.
  • the cores preferably contain 0.1-10 % w/w water.
  • the activity strength of the finished granulate is obtained by mixing the inactive particles with the particles comprising the active compounds.
  • the particles can be mixed before or after applying a coating to the particles. If different amounts of coating have to be applied or it is only one kind of particles that has to be coated, it can be necessary to coat the particles which need a coating before blending the different particles. If both kinds of particles are to be coated with the same coating, it is an advantage to coat them together after blending to avoid one process step, and to obtain particles with the most similar appearance.
  • the invention further relates to a method for preparing a blend comprising inactive particles and particles comprising active compounds comprising the following steps: i) preparing inactive particles; ii) preparing particles comprising an active compound; iii) Mixing the particles of i) and the particles of ii) to a particulate composition. Activity can thus be adjusted by changing the percentage of inactive particles.
  • the present invention may further comprise a coating step in i) and/or ii) or it may comprise a coating step iv).
  • the method of the present invention may further comprise the steps of: v) determining a desired specific activity strength of the final particulate composition; and vi) selecting the amount of particles of i) and the particles of ii) in the right ratio as to obtain the desired specific activity strength determined in v).
  • the method may in a particular embodiment include adjustment of the amount of coating applied to the particles so as to lower the segregation when blending the two kinds of particles.
  • the blend of the present invention is in particular a premix or intermediary product suitable for mixing with another particulate composition or liquid formulation so as to produce a final prod- uct, e.g. a detergent composition, a feed for animal or a dough composition.
  • a final prod- uct e.g. a detergent composition, a feed for animal or a dough composition.
  • the present invention thus comprises a method for preparing a first particulate composition of particles comprising an active compound and inactive particles, said method comprising: i) preparing particles comprising an active compound; ii) preparing inactive particles comprising a coating; iii) blending the particles of i) and ii) to obtain a first particulate composition; iv) mixing the first particulate composition of iii) with a second composition at least one day after preparing the first particulate composition.
  • the first particulate composition of iii) is mixed with a second composition at least 7 days after preparing the first particulate composi- tion. Such as at least 14 days after preparing the first particulate composition. Even at least 1 month after preparing the first particulate composition.
  • the blend of the present invention is expected to be shipped from the place of mixing the two kinds of particles to another geographic location for further processing into a final product.
  • the mixing of the first particulate composi- tion of iii) with a second composition is in a country separate from the country where the first particulate composition was prepared.
  • the first particulate composition is stored and/or shipped to another geographic location prior to mixing it to a second composition.
  • compositions comprising the coated particle and their application
  • the invention also relates to compositions comprising the particle mixture of the invention.
  • the composition may be any composition which may benefit from comprising the particle blend.
  • Suit- able compositions may be but are not limited to detergent compositions, pharmaceutical compositions, compositions for use in the textile, leather or paper industry, compositions for use in the feed or food industry and in the baking industry. Accordingly the compositions may be a feed composition, a food composition, a baking composition, a detergent composition, a pharmaceuti- cal composition or an additive to be incorporated in such compositions.
  • the particles of the invention may be used within the pharmaceutical area, in detergent compositions for cleaning an object, in textile production, in baking for improving bread, in feed compositions for improving the feed and in food products, in personal care products etc.
  • the invention is not to be used in tablets.
  • the blend of the invention is not to be used in further processing such as compression of the blend to tablets.
  • the particle blend of the present invention may be added to and thus become a component of a detergent composition.
  • the particle blend of the invention is preferably not a detergent composition.
  • the detergent composition may for example be formulated as laundry detergent composition for hand or machine washings including a cleaning additive composition suitable for pre-treatment of stained fabrics or a fabric softener composition, or a detergent composition for use in general household hard surface cleaning operations, or a composition for hand or machine dishwashing operations.
  • the invention provides a detergent additive comprising the particle blend of the invention.
  • the detergent additive as well as the detergent composition may comprise one or more other enzymes such as a protease, a lipase, a cutinase, an amylase, a carbohydrase, a cel- lulase, a pectinase, a mannanase, an arabinase, a galactanase, a xylanase, an oxidase, e.g., a laccase, and/or a peroxidase.
  • enzymes such as a protease, a lipase, a cutinase, an amylase, a carbohydrase, a cel- lulase, a pectinase, a mannanase, an arabinase, a galactanase, a xylanas
  • the properties of the chosen enzyme(s) should be compatible with the selected detergent, (i.e. pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.), and the enzyme(s) should be present in effective amounts.
  • proteases include those of animal, vegetable or microbial origin. Microbial origin is preferred. Chemically modified or protein engineered mutants are included.
  • the protease may be a serine protease or a metallo protease, preferably an alkaline microbial protease or a trypsin-like protease.
  • alkaline proteases are subtilisins, especially those derived from Bacillus, e.g., subtilisin Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168 (described in WO 89/06279).
  • trypsin-like proteases are trypsin (e.g. of porcine or bovine origin) and the Fusarium protease described in WO 89/06270 and WO 94/25583.
  • Examples of useful proteases are the variants described in WO 92/19729, WO 98/20115, WO 98/20116, and WO 98/34946, especially the variants with substitutions in one or more of the fol- lowing positions: 27, 36, 57, 76, 87, 97, 101 , 104, 120, 123, 167, 170, 194, 206, 218, 222, 224, 235 and 274.
  • Preferred commercially available protease enzymes include EVERLASETM, OVOZYMETM, SAVOZYMETM, ALCALASETM, SAVINASETM, PRIMASETM, DURALASETM, ESPERASETM, AND KANNASETM (Novozymes A/S), MAXATASETM, MAXACALTM, MAXAPEMTM, PROPERASETM, PURAFECTTM, PURAFECT OXPTM, FN2TM, and FN3TM, FN4TM (Genencor International Inc.).
  • Suitable lipases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful lipases include lipases from Humicola (synonym Thermomyces), e.g. from H. lanuginosa (T. lanuginosus) as described in EP 258 068 and EP 305 216 or from H. insolens as described in WO 96/13580, a Pseudomonas lipase, e.g. from P. alcaligenes or P. pseudoalcaligenes (EP 218 272), P. cepacia (EP 331 376), P. stutzeri (GB 1,372,034), P.
  • lipase variants such as those described in WO 92/05249, WO 94/01541 , EP 407 225, EP 260 105, WO 95/35381 , WO 96/00292, WO 95/30744, WO 94/25578, WO 95/14783, WO 95/22615, WO 97/04079 and WO 97/07202.
  • Preferred commercially available lipase enzymes include LIPOLASETM and LIPOLASE ULTRATM (Novozymes A/S).
  • Amylases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, ⁇ -amylases obtained from Bacillus, e.g. a special strain of B. licheniformis, described in more detail in GB 1 ,296,839.
  • Examples of useful amylases are the variants described in WO 94/02597, WO 94/18314, WO 96/23873, and WO 97/43424, especially the variants with substitutions in one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 181 , 188, 190, 197, 202, 208, 209, 243, 264, 304, 305, 391 , 408, and 444.
  • amylases are DURAMYLTM, TERMAMYLTM, FUNGAMYLTM and BANTM (Novozymes A/S), RAPIDASETM, PURASTARTM and PURASTAR OXAMTM (from Genencor International Inc.).
  • Suitable cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g. the fungal cellulases produced from Humicola insolens, Myceliophthora thermophila and Fusarium oxysporum disclosed in US 4,435,307, US 5,648,263, US 5,691 ,178, US 5,776,757 and WO 89/09259.
  • cellulases are the alkaline or neutral cellulases having colour care benefits.
  • Examples of such cellulases are cellulases described in EP 0 495 257, EP 0 531 372, WO 96/11262, WO 96/29397, WO 98/08940.
  • Other examples are cellulase variants such as those described in WO 94/07998, EP 0 531 315, US 5,457,046, US 5,686,593, US 5,763,254, WO 95/24471 , WO 98/12307 and PCT/DK98/00299.
  • cellulases include CELLUZYMETM, and CAREZYMETM (Novozymes A/S), CLAZINASETM, and PURADAX HATM (Genencor International Inc.), and KAC-500(B) TM (Kao Corporation).
  • Peroxidases/Oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Coprinus, e.g. from C. cinereus, and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257.
  • peroxidases include GUARDZYMETM (Novozymes A/S).
  • Suitable mannanases include MANNAWAYTM(Novozymes A/S).
  • the detergent composition may be in any convenient dry form, e.g., a bar, a tablet, a powder, a granule or a paste. It may also be a liquid detergent, in particular non-aqueous liquid detergent.
  • the detergent composition comprises one or more surfactants, which may be non-ionic including semi-polar and/or anionic and/or cationic and/or zwitterionic.
  • the surfactants are typically present at a level of from 0.1 % to 60% by weight.
  • the detergent When included therein the detergent will usually contain from about 1 % to about 40% of an anionic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, alkyl sulfate (fatty al- cohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsuccinic acid or soap.
  • an anionic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, alkyl sulfate (fatty al- cohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsuccinic acid or soap.
  • the detergent When included therein the detergent will usually contain from about 0.2% to about 40% of a non- ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, alkyldi- methylamineoxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanolamide, poly- hydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine (“glucamides”).
  • a non- ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, alkyldi- methylamineoxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanolamide, poly- hydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine (“glucamides”).
  • the detergent may contain 0-65 % of a detergent builder or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylenediamine- tetraacetic acid, diethylenetriaminepentaacetic acid, alkyl- or alkenylsuccinic acid, soluble silicates or layered silicates (e.g. SKS-6 from Hoechst).
  • a detergent builder or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylenediamine- tetraacetic acid, diethylenetriaminepentaacetic acid, alkyl- or alkenylsuccinic acid, soluble silicates or layered silicates (e.g. SKS-6 from Hoechst).
  • the detergent may comprise one or more polymers.
  • examples are carboxymethylcellulose, poly(vinylpyrrolidone), poly (ethylene glycol), polyvinyl alcohol), poly(vinylpyridine-N-oxide), poly(vinylimidazole), polycarboxylat.es such as polyacrylates, maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers.
  • the detergent may contain a bleaching system, which may comprise a H 2 O 2 source such as perborate or percarbonate, which may be combined with a peracid-forming bleach activator such as tetraacetylethylenediamine or nonanoyloxybenzenesulfonate.
  • a bleaching system may comprise peroxyacids of e.g. the amide, imide, or sulfone type.
  • the enzyme(s) of the detergent composition of the invention may be stabilized using conventional stabilizing agents, e.g., a polyol such as propylene glycol or glycerol, a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid, and the composition may be formulated as described in e.g. WO 92/19709 and WO 92/19708.
  • a polyol such as propylene glycol or glycerol
  • a sugar or sugar alcohol lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid
  • the detergent may also contain other conventional detergent ingredients such as e.g. fabric conditioners including clays, foam boosters, suds suppressors, anti-corrosion agents, soil-suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydrotropes, tarnish inhibitors, or perfumes.
  • fabric conditioners including clays, foam boosters, suds suppressors, anti-corrosion agents, soil-suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydrotropes, tarnish inhibitors, or perfumes.
  • any enzyme may be added in an amount corresponding to 0.01-100 mg of enzyme protein per litre of wash liquor, preferably 0.05- 5 mg of enzyme protein per litre of wash liquor, in particular 0.1-1 mg of enzyme protein per litre of wash liquor.
  • the blend of the invention may additionally be incorporated in the detergent formulations disclosed in WO 97/07202, which is hereby incorporated as reference.
  • the particle size can be changed by applying coatings with deviating density.
  • the density of the final particle will be in between the density of the core and the density of the coating.
  • Several different coating layers may also be applied. Variation of core and coating size will provide particle densities varying between the core and the coating density. This way, inactive granulates can be produced with the required particle densities in order to avoid segregation. Besides, a thick coating also provides equal visual appearance between the inactive particles and the active granulate.
  • Example 1 Sodium sulphate cores with a density of 2.67 g/ml were coated with a sodium sulphate slurry. The density of the coating was 2.03 g/ml. The particle size was increased from the initial 300 micron to 400 micron due to the coating, leading to a final particle density of 2.3 g/ml.
  • Example 4 The coating changed the appearance of sodium sulphate salt core particles from semi- transparent crystals to non-transparent particles. Mixed with other coated, active particles, the inactive particles were visually indistinguishable from the active particles in the mixture.
  • Example 4 The coating changed the appearance of sodium sulphate salt core particles from semi- transparent crystals to non-transparent particles. Mixed with other coated, active particles, the inactive particles were visually indistinguishable from the active particles in the mixture.
  • the inactive particles may differ in particle density from the particles comprising the active ingredient. If the difference is large enough, segregation of the two components may occur for equally sized granulates. The segregation can be reduced by varying the size of the inactive particles relative to the size of the active particles.
  • the table below shows the segregation coefficient of a 50:50 mixture of active particles and inactive particles with a particle density ratio of 0.8.
  • the particle size of the active comprising particles is 450 micron.
  • the particle size of the inactive particles is varied between 450 and 650 micron.
  • the particle density of the active comprising particles is 2.1 g/ml, while the density of the inactive comprising particles is 2.67 g/ml.
  • Table 1 shows the segregation coefficient measured both by heap test and rolling bed as a function of the size ratio between the inactive granules and the active granules.
  • the particle density ratio between the two granulates is 0.8. From table 1 it is seen that by varying the particle size when having different particle densities of the inactive and active particles, it is possible to avoid segregation.
  • the particle density of the active comprising particles was 2.1 g/ml, while the density of the inactive comprising particles was varied from 2.67 g/ml to 2.3 and 2.1 g/ml, where the particle with a density of 2.67 g/ml was a salt particle of 400 micron.
  • the particle density was lowered by means of coatings: a core particle of 300 micron with density 2.67 g/ml was coated up to 400 micron with sodium sulphate slurry. Exchanging 56% of the coating with a starch coating resulted in particles with density 2.1 g/ml.
  • the particle size of the active and inactive particles were all 400 micron.
  • the table below shows the segregation coefficient of 1 :1 mixtures of active and inactive particles.
  • the colour of particles comprising an enzyme and the colour of simple salt cores were measured.
  • the size of the particles were 300 to 400 micron.
  • the colour Lab-values were measured with a HunterLab DP 9000 Model D25M Optical sensor. Before coating, the difference in appearance of the two granulates is very large as seen from the ⁇ E in the table below
  • Spray-dried Protease (Savinase) powder is mixed with Na-sulfate powder and molten Luten- sol AT-80 wax and spray-cooled to obtain spherical prills:
  • Average particle size 273 microns
  • Savinase prills (P1 ) were coated on a fluid bed (Aeromatic MP-1 ) by spraying aqueous slurry of 50% Na-sulfate and 2% Avebe W80 dextrin onto the prills resulting in the following product:
  • Average particle size 443 microns
  • Na-sulfate beads (P2) were coated on a fluid bed (Aeromatic MP-1 ) by spraying aqueous slurry of 33% Na-sulfate, 5% TiO 2 and 2.5% Avebe W80 dextrin onto the beads resulting in the following product:

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Detergent Compositions (AREA)
  • Fodder In General (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Glanulating (AREA)
  • Pigments, Carbon Blacks, Or Wood Stains (AREA)
EP06742446A 2005-06-02 2006-06-02 Blends of inactive particles and active particles Withdrawn EP1890676A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200500805 2005-06-02
PCT/DK2006/000309 WO2006128469A2 (en) 2005-06-02 2006-06-02 Blends of inactive particles and active particles

Publications (1)

Publication Number Publication Date
EP1890676A2 true EP1890676A2 (en) 2008-02-27

Family

ID=35355277

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06742446A Withdrawn EP1890676A2 (en) 2005-06-02 2006-06-02 Blends of inactive particles and active particles

Country Status (4)

Country Link
EP (1) EP1890676A2 (enrdf_load_stackoverflow)
JP (1) JP2008545841A (enrdf_load_stackoverflow)
CN (1) CN101188997A (enrdf_load_stackoverflow)
WO (1) WO2006128469A2 (enrdf_load_stackoverflow)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE028879T2 (en) 2006-07-13 2017-01-30 Dsm Ip Assets Bv Use of bacterial amylases in feed for bovine animals
AR085515A1 (es) * 2011-03-10 2013-10-09 Danisco Us Inc Mezclas de granulos de enzimas que comprenden esencialmente sulfato de sodio
CN102690735A (zh) * 2011-03-10 2012-09-26 丹尼斯科美国公司 基本由硫酸钠组成的酶颗粒掺合物
US10221376B2 (en) 2016-04-18 2019-03-05 Ecolab Usa Inc. Solidification process using low levels of coupler/hydrotrope
JP7680825B2 (ja) * 2017-06-30 2025-05-21 ダニスコ・ユーエス・インク 低凝集の酵素含有粒子
WO2019125683A1 (en) * 2017-12-21 2019-06-27 Danisco Us Inc Enzyme-containing, hot-melt granules comprising a thermotolerant desiccant

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2321673A (en) * 1941-10-11 1943-06-15 Griffith Laboratories Yeast food
GB1095104A (en) * 1966-04-01 1967-12-13 Nu Swift Internat Ltd Improvements in or relating to powders
US3453360A (en) * 1966-04-27 1969-07-01 Abbott Lab Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
IT1168014B (it) * 1981-08-05 1987-05-20 Erba Farmitalia Forme farmaceutiche a cessione protratta
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
GB2290085A (en) * 1994-06-08 1995-12-13 Procter & Gamble Preparation of particulate detergent composition
JP3071427B2 (ja) * 1998-10-09 2000-07-31 花王株式会社 酵素粒子
ES2355123T3 (es) * 1998-11-13 2011-03-23 Danisco Us Inc. Gránulo de baja densidad en lecho fluidizado.
ATE312171T1 (de) * 1999-10-01 2005-12-15 Novozymes As Sprühgetrocknetes enzymprodukt
JP4139089B2 (ja) * 2001-03-15 2008-08-27 花王株式会社 洗浄剤組成物
JP2003105400A (ja) * 2001-09-28 2003-04-09 Lion Corp 粒状洗剤組成物
JP2003138298A (ja) * 2001-10-31 2003-05-14 Kao Corp 洗剤組成物
KR101102273B1 (ko) * 2003-04-24 2012-01-03 라이온 가부시키가이샤 표면처리 수용성 무기 화합물 입자 및 그 제조방법, 및입상 세제 조성물

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2006128469A2 *

Also Published As

Publication number Publication date
WO2006128469A3 (en) 2007-09-27
WO2006128469A2 (en) 2006-12-07
JP2008545841A (ja) 2008-12-18
CN101188997A (zh) 2008-05-28
WO2006128469B1 (en) 2007-11-08

Similar Documents

Publication Publication Date Title
EP1224273B1 (en) Enzyme granulate
ES2436602T3 (es) Proceso para la preparación de un gránulo que contiene enzimas
US7632799B2 (en) Process for preparing coated enzyme granules with salt coatings
US20080292883A1 (en) Granules With Filamentous Coatings
US20060287212A1 (en) Blends of inactive particles and active particles
US6933141B1 (en) Enzyme granulate
EP1324751B1 (en) Coated particles containing an active substance
US20040033927A1 (en) Stabilization of granules
US20050209122A1 (en) Spray dried enzyme product
WO2004003188A2 (en) Stabilization of granules
EP1590455B1 (en) Stabilization of granules
EP1490485B1 (en) Granules with filamentous coatings
WO2006128469A2 (en) Blends of inactive particles and active particles
EP1606381B1 (en) Coated enzyme granules
EP1325102B1 (en) Particles containing active in visco-elastic liquids

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

17P Request for examination filed

Effective date: 20080508

RBV Designated contracting states (corrected)

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

17Q First examination report despatched

Effective date: 20080625

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140103